185 related articles for article (PubMed ID: 18231858)
1. Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection.
Ruggeri C; La Masa AT; Rudi S; Squadrito G; Di Pasquale G; Maimone S; Caccamo G; Pellegrino S; Raimondo G; Magazzù G
Dig Dis Sci; 2008 Aug; 53(8):2151-5. PubMed ID: 18231858
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C.
Muratori P; Muratori L; Guidi M; Granito A; Susca M; Lenzi M; Bianchi FB
Clin Infect Dis; 2005 Feb; 40(4):501-7. PubMed ID: 15712070
[TBL] [Abstract][Full Text] [Related]
3. Coeliac disease and C virus-related chronic hepatitis: a non association.
Gravina AG; Federico A; Masarone M; Cuomo A; Tuccillo C; Loguercio C; Persico M; Romano M
BMC Res Notes; 2012 Sep; 5():533. PubMed ID: 23009068
[TBL] [Abstract][Full Text] [Related]
4. Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot study.
Gatselis NK; Georgiadou SP; Tassopoulos N; Zachou K; Liaskos C; Hatzakis A; Dalekos GN
World J Gastroenterol; 2005 Jan; 11(4):482-7. PubMed ID: 15641130
[TBL] [Abstract][Full Text] [Related]
5. Does an 'autoimmune' profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey.
Stroffolini T; Colloredo G; Gaeta GB; Sonzogni A; Angeletti S; Marignani M; Pasquale G; Venezia G; Craxì A; Almasio P
J Viral Hepat; 2004 May; 11(3):257-62. PubMed ID: 15117328
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases.
Germenis AE; Yiannaki EE; Zachou K; Roka V; Barbanis S; Liaskos C; Adam K; Kapsoritakis AN; Potamianos S; Dalekos GN
Clin Diagn Lab Immunol; 2005 Aug; 12(8):941-8. PubMed ID: 16085912
[TBL] [Abstract][Full Text] [Related]
7. Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.
Betterle C; Fabris P; Zanchetta R; Pedini B; Tositti G; Bosi E; de Lalla F
Diabetes Care; 2000 Aug; 23(8):1177-81. PubMed ID: 10937518
[TBL] [Abstract][Full Text] [Related]
8. Antitissue transglutaminase antibodies outside celiac disease.
Clemente MG; Musu MP; Frau F; Lucia C; De Virgiliis S
J Pediatr Gastroenterol Nutr; 2002 Jan; 34(1):31-4. PubMed ID: 11753161
[TBL] [Abstract][Full Text] [Related]
9. Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients.
Floreani A; Chiaramonte M; Greggio NA; Fabris P; De Lazzari F; Naccarato R; Betterle C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):71-6. PubMed ID: 9615270
[TBL] [Abstract][Full Text] [Related]
10. Human recombinant anti-transglutaminase antibody testing is useful in the diagnosis of silent coeliac disease in a selected group of at-risk patients.
Vivas S; Ruiz de Morales JM; Martinez J; González MC; Martín S; Martín J; Cechini C; Olcoz JL
Eur J Gastroenterol Hepatol; 2003 May; 15(5):479-83. PubMed ID: 12702903
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents.
Terziroli Beretta-Piccoli B; Di Bartolomeo C; Deleonardi G; Grondona AG; Silvestri T; Tesei C; Melidona L; Cerny A; Mertens J; Semmo N; Semela D; Moradpour D; Mieli-Vergani G; Vergani D; Muratori L;
J Autoimmun; 2019 Aug; 102():89-95. PubMed ID: 31047768
[TBL] [Abstract][Full Text] [Related]
12. Silent celiac disease in chronic hepatitis C: impact of interferon treatment on the disease onset and clinical outcome.
Durante-Mangoni E; Iardino P; Resse M; Cesaro G; Sica A; Farzati B; Ruggiero G; Adinolfi LE
J Clin Gastroenterol; 2004; 38(10):901-5. PubMed ID: 15492610
[TBL] [Abstract][Full Text] [Related]
13. Tissue transglutaminase antibodies in celiac disease: assessment of a commercial kit.
Sugai E; Selvaggio G; Vazquez H; Viola M; Mazure R; Pizarro B; Smecuol E; Flores D; Pedreira S; Mauriño E; Gomez JC; Bai JC
Am J Gastroenterol; 2000 Sep; 95(9):2318-22. PubMed ID: 11007235
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody profile in individuals with chronic hepatitis C.
Marconcini ML; Fayad L; Shiozawa MB; Dantas-Correa EB; Lucca Schiavon Ld; Narciso-Schiavon JL
Rev Soc Bras Med Trop; 2013; 46(2):147-53. PubMed ID: 23740063
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study.
Huang MJ; Tsai SL; Huang BY; Sheen IS; Yeh CT; Liaw YF
Clin Endocrinol (Oxf); 1999 Apr; 50(4):503-9. PubMed ID: 10468911
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility to thyroid disorders in hepatitis C.
Muratori L; Bogdanos DP; Muratori P; Lenzi M; Granito A; Ma Y; Mieli-Vergani G; Bianchi FB; Vergani D
Clin Gastroenterol Hepatol; 2005 Jun; 3(6):595-603. PubMed ID: 15952102
[TBL] [Abstract][Full Text] [Related]
18. Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment.
Muratori P; Muratori L; Verucchi G; Attard L; Bianchi FB; Lenzi M
Clin Infect Dis; 2003 Nov; 37(10):1320-6. PubMed ID: 14583865
[TBL] [Abstract][Full Text] [Related]
19. Community-Based Study of Celiac Disease Autoimmunity Progression in Adults.
Choung RS; Khaleghi S; Cartee AK; Marietta EV; Larson JJ; King KS; Savolainen O; Ross AB; Rajkumar SV; Camilleri MJ; Rubio-Tapia A; Murray JA
Gastroenterology; 2020 Jan; 158(1):151-159.e3. PubMed ID: 31560892
[TBL] [Abstract][Full Text] [Related]
20. The prevalence, clinical features and response to antiviral therapy of patients with chronic hepatitis C who are seropositive for liver-kidney microsome type 1 antibodies.
Monti V; Aghemo A; Rumi MG; Donato MF; Del Ninno E; Colombo M
Antivir Ther; 2005; 10(6):715-20. PubMed ID: 16218170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
